Report #2861926

Received Sep 29, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: OK
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Product preparation issue

Symptom narrative

patient was administered only the diluent for the dose of Shingrix and it was not reconstituted with the powder; patient was administered only the diluent for the dose of Shingrix and it was not reconstituted with the powder; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate dose of vaccine administered in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: patient was administered only the diluent for the dose of Shingrix and it was not reconstituted with the powder) and inappropriate preparation of medication (Verbatim: patient was administered only the diluent for the dose of Shingrix and it was not reconstituted with the powder). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date:11-SEP-2025 The patient was administered only the diluent for the dose of Shingrix and it was not reconstituted with the powder.